Center for Molecular Imaging Technology and Translation (CMITT)

Information

  • Research Project
  • 10263161
  • ApplicationId
    10263161
  • Core Project Number
    P41EB022544
  • Full Project Number
    5P41EB022544-05
  • Serial Number
    022544
  • FOA Number
    PAR-13-376
  • Sub Project Id
  • Project Start Date
    9/30/2017 - 7 years ago
  • Project End Date
    6/30/2022 - 2 years ago
  • Program Officer Name
    ATANASIJEVIC, TATJANA
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    9/15/2021 - 3 years ago

Center for Molecular Imaging Technology and Translation (CMITT)

Project Summary / Abstract for the Center for Molecular Imaging Technology and Translation The Center for Molecular Imaging Technology and Translation (CMITT) will be a national resource located within the newly created Gordon Center for Medical Imaging (GCMI) at the Massachusetts General Hospital. Working within the interdisciplinary environment (e.g., imaging sciences; image reconstruction and processing; pharmacokinetics) of the Gordon Center, the aim of CMITT is to develop, validate and disseminate cutting-edge imaging technologies that take advantage of the game-changing capabilities afforded by simultaneous acquisition of PET and MR. CMITT consists of three Technology Research and Development projects (TR&Ds): TR&D1 aims at breaking down the resolution barrier in PET. By developing enabling technologies for attenuation and motion field estimation as well as PSH modeling we can achieve the intrinsic resolution of PET, about 4mm, in the breathing patient by using novel accelerated MR acquisitions with sparse sampling. TR&D2 will develop the unified statistical model of joint reconstruction of PET and MR that incorporates the corrections developed in TR&D1. TR&D3 will develop the pharmacokinetic modeling of physiological processes in simultaneous PET/MR (TR&D3) in quantitative PET/MR images that enable exploration of molecular physiology. There is currently no PET-focused Biomedical Technology Resource Center supported by NIBIB. Thus CMITT seeks to fill a clear national need for PET/MR imaging technology development, one that is agnostic with respect to commercial platform and, in many instances, applies equally to PET or MR alone. The Resource provides a unique environment with an interdisciplinary team of highly accomplished scientists, engineers, and clinicians with diverse expertise in multiple modalities and disciplines that supports service use of the Center's facilities by imaging scientists throughout the country as well as Europe, Asia and Australia. CMITT will provide extensive training opportunities for students, post-doctoral fellows, and faculty, and seeks to advance the field of molecular imaging of normal function and disease through active dissemination of new knowledge and technology.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    P41
  • Administering IC
    EB
  • Application Type
    5
  • Direct Cost Amount
    734698
  • Indirect Cost Amount
    455511
  • Total Cost
    1190209
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
  • Funding ICs
    NIBIB:1190209\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZEB1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MASSACHUSETTS GENERAL HOSPITAL
  • Organization Department
  • Organization DUNS
    073130411
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021142621
  • Organization District
    UNITED STATES